The second iteration of the I’m A Celebrity spin-off series, titled All-Stars, has finalized its cast roster for production in South Africa. The format represents a shift from the original Australian-based jungle location to the South African wilderness, concentrating on returning "fan favorites" and legacy contestants.

Core participants include:
Harry Redknapp (Football Manager)
Gemma Collins (Reality Personality)
Beverley Callard (Soap Actress)
Mo Farah (Olympian)
Scarlett Moffatt (Television Personality)
Adam Thomas (Soap Actor)
Jimmy Bullard (Former Premier League Footballer)
| Feature | Details |
|---|---|
| Location | South African wilderness (formerly Kruger National Park) |
| Production Cycle | Series Two |
| Winner Selection | Live audience vote via London grand final |
| Structural Change | Elevated difficulty in physical trials |
Tactical Nostalgia and Recycled Celebrity
The strategy hinges on the "legacy" appeal of participants who have already navigated the production's behavioral trials. By recycling familiar archetypes—the soap legend, the retired athlete, and the reality veteran—the broadcaster attempts to stabilize viewership by banking on established parasocial attachments.
The inclusion of specific contestants like Adam Thomas, cited for his high frequency of "Bushtucker" trial completions, signals a prioritization of high-stakes physical participation over original social discovery. The framing suggests that physical endurance and personal "redemption" arcs remain the primary currency of this entertainment model.
Read More: Timothée Chalamet comments on ballet and opera lead to backlash from artists

Industry Background
The "All-Stars" offshoot emerged as a strategic expansion of the original franchise, which historically relied on importing participants into a contained environment to induce stress responses for entertainment. The South African edition deviates by intensifying the barrier of entry, essentially turning the program into a tournament of professional "campmates."

Previous iterations of the show have frequently become sites for broader cultural narratives—most notably the 2022 inclusion of a former Health Secretary—suggesting that the production serves as both a mechanism for image management and a test of audience loyalty. This second series aims to capitalize on the predictability of the brand by stripping away the unknown and refining the trial mechanics to ensure maximum exposure for returning names.